- Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
- The regulation, functions, and signaling of miR-153 in neurological disorders and its potential as a biomarker and therapeutic target
- Brain, cognitive, and physical disability correlates of decreased quality of life in patients with Huntington's disease
- Cerebral blood flow is associated with markers of neurodegeneration in Huntington's disease
- Carnosol Reduced Pathogenic Protein Aggregation and Cognitive Impairment in Neurodegenerative Diseases Models via Improving Proteostasis and Ameliorating Mitochondrial Disorders
- Using Machine Learning to identify microRNA biomarkers for predisposition to Juvenile Onset Huntington's Disease
- CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes
- Time-Restricted Ketogenic Diet in Huntington's Disease: A Case Study
- Huntingtin-KIF1A-mediated axonal transport of synaptic vesicle precursors influences synaptic transmission and motor skill learning in mice
- Design, implementation, and functional validation of a new generation of microneedle 3D high-density CMOS multi-electrode array for brain tissue and spheroids
- Patient and Caregiver Perspectives on Telehealth Use in a Multidisciplinary Huntington's Disease Clinic: A Single-Institution Experience
- An Exploratory Study Investigating Autonomy in Huntington's Disease Gene Expansion Carriers
- A mechanism of uncompetitive inhibition of the serotonin transporter
- Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience
- Emerging Role of NLRP3 Inflammasome/Pyroptosis in Huntington's Disease
- Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders
- Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders
- Selective Serotonin Reuptake Inhibitors Within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane
- Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases
- Expanding Arsenal against Neurodegenerative Diseases using Quercetin based Nanoformulations: Breakthroughs and Bottlenecks
- mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
- 'High-Density-SleepCleaner': An open-source, semi-automatic artifact removal routine tailored to high-density sleep EEG
- Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
- Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases
- REViewer: haplotype-resolved visualization of read alignments in and around tandem repeats
- Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington's disease
- TRIM family proteins: roles in proteostasis and neurodegenerative diseases
- Investigating resting state neurophysiological markers of apathy and processing speed in prodromal and early-stage manifest Huntington's disease
- A pathogenic proteolysis-resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function
- Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial
- Targeting Endoplasmic Reticulum Stress using Natural Products in Neurological Disorders
- Pregnancy FcEAte: Huntington's Pantoum
- Quantifying Huntingtin Protein in Human Cerebrospinal Fluid Using a Novel Polyglutamine Length-Independent Assay
- A probable <em>cis</em>-acting genetic modifier of Huntington disease frequent in individuals with African ancestry
- Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism
- Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
- Construction of QSAR model based on cysteine-containing dipeptides and screening of natural tyrosinase inhibitors
- HTT-OMNI: A Web-based Platform for Huntingtin Interaction Exploration and Multi-omics Data Integration
- The CRTC-CREB axis functions as a transcriptional sensor to protect against proteotoxic stress in Drosophila
- Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
- Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC-derived neurons
- Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases
- A multi-modal fitting approach to construct single-neuron models with patch clamp and high-density microelectrode arrays
- Clinical and molecular findings of intermediate allele carriers in the HTT gene from the Mexican Mestizo population
- Social support experiences when growing up with a parent with Huntington's disease
- HD-PTP/PTPN23 hypomorphic mice display lipodystrophy
- A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders
- Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease
- Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes
- Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders
- Dance therapy in the rehabilitation of neurological diseases
- Huntingtin turnover: modulation of huntingtin degradation by cAMP-dependent protein kinase A (PKA) phosphorylation of C-HEAT domain Ser2550
- Integrated transcriptome analysis of Huntingtons disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation
- The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders
- Dilemmas when talking about Huntington's disease: A qualitative study of offspring and caregiver experiences in Norway
- Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort
- Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease
- A Primer Genetic Toolkit for Exploring Mitochondrial Biology and Disease Using Zebrafish
- Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents
- New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism
- Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases
- Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington's Disease: A Descriptive, Evidence-Based Model
- Renin-Angiotensin System in Huntington's Disease: Evidence from Animal Models and Human Patients
- Differential Cellular Balance of Olfactory and Vomeronasal Epithelia in a Transgenic BACHD Rat Model of Huntington's Disease
- Modelling the Human Blood-Brain Barrier in Huntington Disease
- Effect of Immersive Virtual Reality by a Computer Assisted Rehabilitation Environment (CAREN) in Juvenile Huntington's Disease: A Case Report
- GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
- Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model
- Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data
- Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats
- Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease
- Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease
- Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease
- Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route
- Widespread alterations in microRNA biogenesis in human Huntington's disease putamen
- Differential regulation of Tau exon 2 and 10 isoforms in Huntington's disease brain
- Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats
- Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation
- Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies
- Protective Effects of Polysaccharides in Neurodegenerative Diseases
- Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
- Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review
- Quantitative NMR analysis of the kinetics of prenucleation oligomerization and aggregation of pathogenic huntingtin exon-1 protein
- Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease
- p53 TAD2 Domain (38-61) Forms Amyloid-like Aggregates in Isolation
- Reply to: An MDS Evidence-Based Review on Treatments for Huntington's Disease
- An MDS Evidence-Based Review on Treatments for Huntington's Disease
- Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases
- Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
- Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders
- Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies
- HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis
- Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
- Tolfenamic acid inhibits ROS-generating oxidase Nox1-regulated p53 activity in intrastriatal injection of malonic acid rats
- Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis
- Atypical parkinsonism can be a presenting feature of late-onset Huntington's disease
- Autophagy in health and disease: From molecular mechanisms to therapeutic target
- Recent Microscopy Advances and the Applications to Huntington's Disease Research
- An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different tribes in 6 sub-Saharan African countries
RSS Feed – Literature
HDinHD > RSS Feed – Literature
